Gary W. Falk, MD, MS / Ikuo Hirano, MD - Enhancing Outcomes in Adults and Children With Eosinophilic Esophagitis by Targeting Type 2 Inflammation

Please visit answersincme.com/HQX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the treatment of eosinophilic esophagitis (EoE) discuss biologic therapies targeting type 2 inflammation. Upon completion of this activity, participants should be better able to: Identify the role of type 2 inflammation in EoE in the context of treatment implications; and Describe evidence-based strategies to integrate biologics targeting type 2 inflammation into clinical practice for the management of EoE.